Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 313

1.

VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study.

Chang JE, Carmichael LL, Kim K, Peterson C, Yang DT, Traynor AM, Werndli JE, Huie MS, McFarland TA, Volk M, Blank J, Callander NS, Longo WL, Kahl BS.

Clin Lymphoma Myeloma Leuk. 2018 Jan;18(1):e61-e67. doi: 10.1016/j.clml.2017.10.006. Epub 2017 Nov 4.

2.

Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group.

Erbe AK, Wang W, Carmichael L, Kim K, Mendonça EA, Song Y, Hess D, Reville PK, London WB, Naranjo A, Hank JA, Diccianni MB, Reisfeld RA, Gillies SD, Matthay KK, Cohn SL, Hogarty MD, Maris JM, Park JR, Ozkaynak MF, Gilman AL, Yu AL, Sondel PM.

Clin Cancer Res. 2018 Jan 1;24(1):189-196. doi: 10.1158/1078-0432.CCR-17-1767. Epub 2017 Oct 2.

PMID:
28972044
3.

Household food insecurity and dietary patterns in rural and urban American Indian families with young children.

Tomayko EJ, Mosso KL, Cronin KA, Carmichael L, Kim K, Parker T, Yaroch AL, Adams AK.

BMC Public Health. 2017 Jun 30;17(1):611. doi: 10.1186/s12889-017-4498-y.

4.

HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy.

Erbe AK, Wang W, Reville PK, Carmichael L, Kim K, Mendonca EA, Song Y, Hank JA, London WB, Naranjo A, Hong F, Hogarty MD, Maris JM, Park JR, Ozkaynak MF, Miller JS, Gilman AL, Kahl B, Yu AL, Sondel PM.

Front Immunol. 2017 Jun 12;8:675. doi: 10.3389/fimmu.2017.00675. eCollection 2017.

5.

Defining Disease, Diagnosis, and Translational Medicine within a Homeostatic Perturbation Paradigm: The National Institutes of Health Undiagnosed Diseases Program Experience.

Gall T, Valkanas E, Bello C, Markello T, Adams C, Bone WP, Brandt AJ, Brazill JM, Carmichael L, Davids M, Davis J, Diaz-Perez Z, Draper D, Elson J, Flynn ED, Godfrey R, Groden C, Hsieh CK, Fischer R, Golas GA, Guzman J, Huang Y, Kane MS, Lee E, Li C, Links AE, Maduro V, Malicdan MCV, Malik FS, Nehrebecky M, Park J, Pemberton P, Schaffer K, Simeonov D, Sincan M, Smedley D, Valivullah Z, Wahl C, Washington N, Wolfe LA, Xu K, Zhu Y, Gahl WA, Tifft CJ, Toro C, Adams DR, He M, Robinson PN, Haendel MA, Zhai RG, Boerkoel CF.

Front Med (Lausanne). 2017 May 26;4:62. doi: 10.3389/fmed.2017.00062. eCollection 2017.

6.

Assessing histone demethylase inhibitors in cells: lessons learned.

Hatch SB, Yapp C, Montenegro RC, Savitsky P, Gamble V, Tumber A, Ruda GF, Bavetsias V, Fedorov O, Atrash B, Raynaud F, Lanigan R, Carmichael L, Tomlin K, Burke R, Westaway SM, Brown JA, Prinjha RK, Martinez ED, Oppermann U, Schofield CJ, Bountra C, Kawamura A, Blagg J, Brennan PE, Rossanese O, Müller S.

Epigenetics Chromatin. 2017 Mar 1;10:9. doi: 10.1186/s13072-017-0116-6. eCollection 2017.

7.

Phase 1b study of orteronel in postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancer.

Rampurwala M, Wisinski KB, Burkard ME, Ehsani S, O'Regan RM, Carmichael L, Kim K, Kolesar J, Tevaarwerk AJ.

Invest New Drugs. 2017 Feb;35(1):87-94. doi: 10.1007/s10637-016-0403-2. Epub 2016 Nov 8.

8.

18F-FLT PET/CT imaging in patients with advanced solid malignancies treated with axitinib on an intermittent dosing regimen.

Scarpelli M, Bruce JY, Carmichael L, Eickhoff J, Kolesar J, Perlman S, Jeraj R, Liu G.

Cancer Chemother Pharmacol. 2016 Dec;78(6):1245-1252. Epub 2016 Nov 5.

9.

FCGR Polymorphisms Influence Response to IL2 in Metastatic Renal Cell Carcinoma.

Erbe AK, Wang W, Goldberg J, Gallenberger M, Kim K, Carmichael L, Hess D, Mendonca EA, Song Y, Hank JA, Cheng SC, Signoretti S, Atkins M, Carlson A, Mier JW, Panka DJ, McDermott DF, Sondel PM.

Clin Cancer Res. 2017 May 1;23(9):2159-2168. doi: 10.1158/1078-0432.CCR-16-1874. Epub 2016 Oct 14.

PMID:
27742794
10.

Killer immunoglobulin-like receptor (KIR) and KIR-ligand genotype do not correlate with clinical outcome of renal cell carcinoma patients receiving high-dose IL2.

Wang W, Erbe AK, Gallenberger M, Kim K, Carmichael L, Hess D, Mendonca EA, Song Y, Hank JA, Cheng SC, Signoretti S, Atkins M, Carlson A, Weiss JM, Mier J, Panka D, McDermott DF, Sondel PM.

Cancer Immunol Immunother. 2016 Dec;65(12):1523-1532. Epub 2016 Sep 30.

11.

Integrated Analysis of Multiple Biomarkers from Circulating Tumor Cells Enabled by Exclusion-Based Analyte Isolation.

Sperger JM, Strotman LN, Welsh A, Casavant BP, Chalmers Z, Horn S, Heninger E, Thiede SM, Tokar J, Gibbs BK, Guckenberger DJ, Carmichael L, Dehm SM, Stephens PJ, Beebe DJ, Berry SM, Lang JM.

Clin Cancer Res. 2016 Jul 11. doi: 10.1158/1078-0432.CCR-16-1021. [Epub ahead of print]

12.

A Phase II Trial of a Histone Deacetylase Inhibitor Panobinostat in Patients With Low-Grade Neuroendocrine Tumors.

Jin N, Lubner SJ, Mulkerin DL, Rajguru S, Carmichael L, Chen H, Holen KD, LoConte NK.

Oncologist. 2016 Jul;21(7):785-6. doi: 10.1634/theoncologist.2016-0060. Epub 2016 Jun 3.

13.

In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments.

Morris ZS, Guy EI, Francis DM, Gressett MM, Werner LR, Carmichael LL, Yang RK, Armstrong EA, Huang S, Navid F, Gillies SD, Korman A, Hank JA, Rakhmilevich AL, Harari PM, Sondel PM.

Cancer Res. 2016 Jul 1;76(13):3929-41. doi: 10.1158/0008-5472.CAN-15-2644. Epub 2016 May 6.

14.

Sorcin Links Pancreatic β-Cell Lipotoxicity to ER Ca2+ Stores.

Marmugi A, Parnis J, Chen X, Carmichael L, Hardy J, Mannan N, Marchetti P, Piemonti L, Bosco D, Johnson P, Shapiro JA, Cruciani-Guglielmacci C, Magnan C, Ibberson M, Thorens B, Valdivia HH, Rutter GA, Leclerc I.

Diabetes. 2016 Apr;65(4):1009-21. doi: 10.2337/db15-1334. Epub 2016 Jan 28.

15.

Genome Modeling System: A Knowledge Management Platform for Genomics.

Griffith M, Griffith OL, Smith SM, Ramu A, Callaway MB, Brummett AM, Kiwala MJ, Coffman AC, Regier AA, Oberkfell BJ, Sanderson GE, Mooney TP, Nutter NG, Belter EA, Du F, Long RL, Abbott TE, Ferguson IT, Morton DL, Burnett MM, Weible JV, Peck JB, Dukes A, McMichael JF, Lolofie JT, Derickson BR, Hundal J, Skidmore ZL, Ainscough BJ, Dees ND, Schierding WS, Kandoth C, Kim KH, Lu C, Harris CC, Maher N, Maher CA, Magrini VJ, Abbott BS, Chen K, Clark E, Das I, Fan X, Hawkins AE, Hepler TG, Wylie TN, Leonard SM, Schroeder WE, Shi X, Carmichael LK, Weil MR, Wohlstadter RW, Stiehr G, McLellan MD, Pohl CS, Miller CA, Koboldt DC, Walker JR, Eldred JM, Larson DE, Dooling DJ, Ding L, Mardis ER, Wilson RK.

PLoS Comput Biol. 2015 Jul 9;11(7):e1004274. doi: 10.1371/journal.pcbi.1004274. eCollection 2015 Jul.

16.

Pharmacodynamic study of axitinib in patients with advanced malignancies assessed with (18)F-3'deoxy-3'fluoro-L-thymidine positron emission tomography/computed tomography.

Bruce JY, Scully PC, Carmichael LL, Eickhoff JC, Perlman SB, Kolesar JM, Heideman JL, Jeraj R, Liu G.

Cancer Chemother Pharmacol. 2015 Jul;76(1):187-95. doi: 10.1007/s00280-015-2779-7. Epub 2015 May 29.

17.

Hepatitis C: extrahepatic manifestations.

Metts J, Carmichael L, Kokor W, Scharffenberg R.

FP Essent. 2014 Dec;427:32-5.

PMID:
25478648
18.

Hepatitis C: liver transplantation.

Metts J, Carmichael L, Kokor W, Scharffenberg R.

FP Essent. 2014 Dec;427:25-31.

PMID:
25478647
19.

Hepatitis C: existing and new treatments.

Metts J, Carmichael L, Kokor W, Scharffenberg R.

FP Essent. 2014 Dec;427:18-24.

PMID:
25478646
20.

Hepatitis C: prevalence, transmission, screening, and prevention.

Metts J, Carmichael L, Kokor W, Scharffenberg R.

FP Essent. 2014 Dec;427:11-7.

PMID:
25478645
21.

A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors.

LoConte NK, Razak AR, Ivy P, Tevaarwerk A, Leverence R, Kolesar J, Siu L, Lubner SJ, Mulkerin DL, Schelman WR, Deming DA, Holen KD, Carmichael L, Eickhoff J, Liu G.

Invest New Drugs. 2015 Feb;33(1):169-76. doi: 10.1007/s10637-014-0166-6. Epub 2014 Oct 17.

22.

A phase I pharmacodynamic trial of sequential sunitinib with bevacizumab in patients with renal cell carcinoma and other advanced solid malignancies.

Bruce JY, Kolesar JM, Hammers H, Stein MN, Carmichael L, Eickhoff J, Johnston SA, Binger KA, Heideman JL, Perlman SB, Jeraj R, Liu G.

Cancer Chemother Pharmacol. 2014 Mar;73(3):485-93. doi: 10.1007/s00280-013-2373-9. Epub 2014 Jan 12.

23.

Prostate cancer screening for men aged 75 to 84 years in New South Wales.

Carmichael LK, Goldsbury DE, O'Connell DL.

Aust N Z J Public Health. 2013 Oct;37(5):492-4. doi: 10.1111/1753-6405.12115. No abstract available.

PMID:
24090337
24.

Viral reproductive pathogens of dogs and cats.

Decaro N, Carmichael LE, Buonavoglia C.

Vet Clin North Am Small Anim Pract. 2012 May;42(3):583-98, vii. doi: 10.1016/j.cvsm.2012.01.006. Epub 2012 Mar 3. Review.

PMID:
22482820
25.

The effectiveness of health appraisal processes currently in addressing health and wellbeing during spatial plan appraisal: a systematic review.

Gray S, Carmichael L, Barton H, Mytton J, Lease H, Joynt J.

BMC Public Health. 2011 Nov 24;11:889. doi: 10.1186/1471-2458-11-889. Review.

26.

Pharmacodynamic study using FLT PET/CT in patients with renal cell cancer and other solid malignancies treated with sunitinib malate.

Liu G, Jeraj R, Vanderhoek M, Perlman S, Kolesar J, Harrison M, Simoncic U, Eickhoff J, Carmichael L, Chao B, Marnocha R, Ivy P, Wilding G.

Clin Cancer Res. 2011 Dec 15;17(24):7634-44. doi: 10.1158/1078-0432.CCR-11-1677. Epub 2011 Oct 28.

27.

Pulses of movement across the sea ice: population connectivity and temporal genetic structure in the arctic fox.

Norén K, Carmichael L, Fuglei E, Eide NE, Hersteinsson P, Angerbjörn A.

Oecologia. 2011 Aug;166(4):973-84. doi: 10.1007/s00442-011-1939-7. Epub 2011 Feb 23.

PMID:
21344255
28.

Lights and shades on an historical vaccine canine distemper virus, the Rockborn strain.

Martella V, Blixenkrone-Møller M, Elia G, Lucente MS, Cirone F, Decaro N, Nielsen L, Bányai K, Carmichael LE, Buonavoglia C.

Vaccine. 2011 Feb 1;29(6):1222-7. doi: 10.1016/j.vaccine.2010.12.001. Epub 2010 Dec 15.

PMID:
21167117
29.

Genetic heterogeneity and recombination in canine noroviruses.

Martella V, Decaro N, Lorusso E, Radogna A, Moschidou P, Amorisco F, Lucente MS, Desario C, Mari V, Elia G, Banyai K, Carmichael LE, Buonavoglia C.

J Virol. 2009 Nov;83(21):11391-6. doi: 10.1128/JVI.01385-09. Epub 2009 Aug 26.

30.

Recurring mutations found by sequencing an acute myeloid leukemia genome.

Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K, Koboldt DC, Fulton RS, Delehaunty KD, McGrath SD, Fulton LA, Locke DP, Magrini VJ, Abbott RM, Vickery TL, Reed JS, Robinson JS, Wylie T, Smith SM, Carmichael L, Eldred JM, Harris CC, Walker J, Peck JB, Du F, Dukes AF, Sanderson GE, Brummett AM, Clark E, McMichael JF, Meyer RJ, Schindler JK, Pohl CS, Wallis JW, Shi X, Lin L, Schmidt H, Tang Y, Haipek C, Wiechert ME, Ivy JV, Kalicki J, Elliott G, Ries RE, Payton JE, Westervelt P, Tomasson MH, Watson MA, Baty J, Heath S, Shannon WD, Nagarajan R, Link DC, Walter MJ, Graubert TA, DiPersio JF, Wilson RK, Ley TJ.

N Engl J Med. 2009 Sep 10;361(11):1058-66. doi: 10.1056/NEJMoa0903840. Epub 2009 Aug 5.

31.

Notched audiograms and noise exposure history in older adults.

Nondahl DM, Shi X, Cruickshanks KJ, Dalton DS, Tweed TS, Wiley TL, Carmichael LL.

Ear Hear. 2009 Dec;30(6):696-703. doi: 10.1097/AUD.0b013e3181b1d418.

32.

Changes in hearing thresholds over 10 years in older adults.

Wiley TL, Chappell R, Carmichael L, Nondahl DM, Cruickshanks KJ.

J Am Acad Audiol. 2008 Apr;19(4):281-92; quiz 371.

33.

Detection and molecular characterization of a canine norovirus.

Martella V, Lorusso E, Decaro N, Elia G, Radogna A, D'Abramo M, Desario C, Cavalli A, Corrente M, Camero M, Germinario CA, Bányai K, Di Martino B, Marsilio F, Carmichael LE, Buonavoglia C.

Emerg Infect Dis. 2008 Aug;14(8):1306-8. doi: 10.3201/eid1408.080062.

34.

Olfaction and the 5-year incidence of cognitive impairment in an epidemiological study of older adults.

Schubert CR, Carmichael LL, Murphy C, Klein BE, Klein R, Cruickshanks KJ.

J Am Geriatr Soc. 2008 Aug;56(8):1517-21. doi: 10.1111/j.1532-5415.2008.01826.x. Epub 2008 Jul 24.

35.

Design and implementation of a generalized laboratory data model.

Wendl MC, Smith S, Pohl CS, Dooling DJ, Chinwalla AT, Crouse K, Hepler T, Leong S, Carmichael L, Nhan M, Oberkfell BJ, Mardis ER, Hillier LW, Wilson RK.

BMC Bioinformatics. 2007 Sep 26;8:362.

36.

Historical and ecological determinants of genetic structure in arctic canids.

Carmichael LE, Krizan J, Nagy JA, Fuglei E, Dumond M, Johnson D, Veitch A, Berteaux D, Strobeck C.

Mol Ecol. 2007 Aug;16(16):3466-83.

PMID:
17688546
37.

DLA-DRB1, DQA1, and DQB1 alleles and haplotypes in North American Gray Wolves.

Kennedy LJ, Angles JM, Barnes A, Carmichael LE, Radford AD, Ollier WE, Happ GM.

J Hered. 2007;98(5):491-9. Epub 2007 Jul 4.

PMID:
17611255
38.

Genotyping canine distemper virus (CDV) by a hemi-nested multiplex PCR provides a rapid approach for investigation of CDV outbreaks.

Martella V, Elia G, Lucente MS, Decaro N, Lorusso E, Banyai K, Blixenkrone-Møller M, Lan NT, Yamaguchi R, Cirone F, Carmichael LE, Buonavoglia C.

Vet Microbiol. 2007 May 16;122(1-2):32-42. Epub 2007 Jan 16.

PMID:
17275219
39.

Heterogeneity within the hemagglutinin genes of canine distemper virus (CDV) strains detected in Italy.

Martella V, Cirone F, Elia G, Lorusso E, Decaro N, Campolo M, Desario C, Lucente MS, Bellacicco AL, Blixenkrone-Møller M, Carmichael LE, Buonavoglia C.

Vet Microbiol. 2006 Sep 10;116(4):301-9. Epub 2006 Apr 27.

PMID:
16730927
40.
41.

2006 AAHA canine vaccine guidelines.

American Animal Hospital Association (AAHA) Canine Vaccine Task Force, Paul MA, Carmichael LE, Childers H, Cotter S, Davidson A, Ford R, Hurley KF, Roth JA, Schultz RD, Thacker E, Welborn L.

J Am Anim Hosp Assoc. 2006 Mar-Apr;42(2):80-9.

PMID:
16527908
42.

An annotated historical account of canine parvovirus.

Carmichael LE.

J Vet Med B Infect Dis Vet Public Health. 2005 Sep-Oct;52(7-8):303-11.

PMID:
16316389
43.

Cerebral blood flow during spontaneous and cholinergically induced behavioral states in the sheep fetus.

Morrison JL, Carmichael L, Homan J, White S, Richardson BS.

Pediatr Res. 2005 May;57(5 Pt 1):667-73. Epub 2005 Feb 17.

PMID:
15718367
44.

Placental compared with umbilical cord blood to assess fetal blood gas and acid-base status.

Nodwell A, Carmichael L, Ross M, Richardson B.

Obstet Gynecol. 2005 Jan;105(1):129-38.

PMID:
15625154
45.

Safety and efficacy of a modified-live canine coronavirus vaccine in dogs.

Pratelli A, Tinelli A, Decaro N, Martella V, Camero M, Tempesta M, Martini M, Carmichael LE, Buonavoglia C.

Vet Microbiol. 2004 Mar 26;99(1):43-9.

PMID:
15019110
46.
47.

Photostimulated luminescence detection of irradiated shellfish: international interlaboratory trial.

Sanderson DC, Carmichael LA, Fisk S.

J AOAC Int. 2003 Sep-Oct;86(5):983-9.

PMID:
14632401
48.

Thermoluminescence detection of irradiated shellfish: international interlaboratory trial.

Sanderson DC, Carmichael LA, Fisk S.

J AOAC Int. 2003 Sep-Oct;86(5):976-82.

PMID:
14632400
49.

Thermoluminescence detection of irradiated fruits and vegetables: international interlaboratory trial.

Sanderson DC, Carmichael LA, Fisk S.

J AOAC Int. 2003 Sep-Oct;86(5):971-5.

PMID:
14632399
50.

Fatal coronavirus infection in puppies following canine parvovirus 2b infection.

Pratelli A, Tempesta M, Roperto FP, Sagazio P, Carmichael L, Buonavoglia C.

J Vet Diagn Invest. 1999 Nov;11(6):550-3. No abstract available.

PMID:
12968743

Supplemental Content

Loading ...
Support Center